Tafamidis for Transthyretin Familial Polyneuropathy (TTR-FAP): Evidence Review Group assessment of manufacturer submission for the Advisory Group for National Specialised Services.

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherCentre for Reviews and Dissemination/ Centre for Health Economics
Number of pages187
Publication statusPublished - 2013

Cite this